PMID- 22916213 OWN - NLM STAT- MEDLINE DCOM- 20130116 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 8 DP - 2012 TI - Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice. PG - e43107 LID - 10.1371/journal.pone.0043107 [doi] LID - e43107 AB - BACKGROUND: The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in conditioned place preference (CPP) procedures, but the involvement of the dopaminergic system in MDMA-induced CPP and reinstatement is poorly understood. METHODOLOGY/PRINCIPAL FINDINGS: In this study, the effects of the DA D1 antagonist SCH 23390 (0.125 and 0.250 mg/kg), the DA D2 antagonist Haloperidol (0.1 and 0.2 mg/kg), the D2 antagonist Raclopride (0.3 and 0.6 mg/kg) and the dopamine release inhibitor CGS 10746B (3 and 10 mg/kg) on the acquisition, expression and reinstatement of a CPP induced by 10 mg/kg of MDMA were evaluated in adolescent mice. As expected, MDMA significantly increased the time spent in the drug-paired compartment during the post-conditioning (Post-C) test, and a priming dose of 5 mg/kg reinstated the extinguished preference. The higher doses of Haloperidol, Raclopride and CGS 10746B and both doses of SCH 23390 blocked acquisition of the MDMA-induced CPP. However, only Haloperidol blocked expression of the CPP. Reinstatement of the extinguished preference was not affected by any of the drugs studied. Analysis of brain monoamines revealed that the blockade of CPP acquisition was accompanied by an increase in DA concentration in the striatum, with a concomitant decrease in DOPAC and HVA levels. Administration of haloperidol during the Post-C test produced increases in striatal serotonin, DOPAC and HVA concentrations. In mice treated with the higher doses of haloperidol and CGS an increase in SERT concentration in the striatum was detected during acquisition of the CPP, but no changes in DAT were observed. CONCLUSIONS/SIGNIFICANCE: These results demonstrate that, in adolescent mice, the dopaminergic system is involved in the acquisition and expression of MDMA-induced CPP, but not in its reinstatement. FAU - Vidal-Infer, Antonio AU - Vidal-Infer A AD - Unit of Research on Psychobiology of Drug Dependence, University of Valencia, Valencia, Spain. FAU - Roger-Sanchez, Concepcion AU - Roger-Sanchez C FAU - Daza-Losada, Manuel AU - Daza-Losada M FAU - Aguilar, Maria A AU - Aguilar MA FAU - Minarro, Jose AU - Minarro J FAU - Rodriguez-Arias, Marta AU - Rodriguez-Arias M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120816 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Benzazepines) RN - 0 (Dopamine Antagonists) RN - 0 (SCH 23390) RN - 0 (Thiazepines) RN - 333DO1RDJY (Serotonin) RN - 430K3SOZ7G (Raclopride) RN - 81382-52-7 (CGS 10746B) RN - J6292F8L3D (Haloperidol) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - VTD58H1Z2X (Dopamine) SB - IM MH - Animals MH - Benzazepines/pharmacology MH - Blotting, Western MH - Conditioning, Operant/*drug effects MH - Dopamine/*metabolism MH - Dopamine Antagonists/pharmacology MH - Haloperidol/pharmacology MH - Male MH - Mice MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - Raclopride/pharmacology MH - Serotonin/metabolism MH - Thiazepines/pharmacology PMC - PMC3420895 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2012/08/24 06:00 MHDA- 2013/01/17 06:00 PMCR- 2012/08/16 CRDT- 2012/08/24 06:00 PHST- 2011/11/21 00:00 [received] PHST- 2012/07/19 00:00 [accepted] PHST- 2012/08/24 06:00 [entrez] PHST- 2012/08/24 06:00 [pubmed] PHST- 2013/01/17 06:00 [medline] PHST- 2012/08/16 00:00 [pmc-release] AID - PONE-D-11-23518 [pii] AID - 10.1371/journal.pone.0043107 [doi] PST - ppublish SO - PLoS One. 2012;7(8):e43107. doi: 10.1371/journal.pone.0043107. Epub 2012 Aug 16.